Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
🤡 🤣
What a joke. Can’t even spell. Sadly- some here may not even see the error 😂
http://marketingworldwide.co/
Why I ask you???
Read this https://praisecharlotte.com/908215/robert-blagman-shares-amazing-testimony-of-gods-grace/
Then ask yourself...
Why would he start another public company if he lost millions from his crooks; was so distraught form going after them; lost his gospel ministry; fined 1 million dollars?
I wonder why he is no longer in the gospel music business. toxic maybe? ☠️
Who, in their right mind would hire this guy as a consultant? - unless they need help with dealing with the FBI and the SEC!
But .... people can change right. right?
What stock are you talking about? Not TBLT.
How sad.
What is a pincher top?
That is what I am asking this board. Are they the same? Same product name. Very odd.
New here. Can you clarify a couple of things?
1.) I see BRK Inc won a suit against iSee Automation. I also see that iSee Sports is a subsidiary of BRK Inc. Are these two different companies, iSee Automation and iSee Sports? If they are the same, how can you win a settlement against your own company? I know BRK Inc bought the technology from iSee Automation. I was just wondering if they acquired the company.
2.) Refcam? Is that the same as the iSee Refcam? Refcam is referenced in a 2017 Yahoo article talking about BRK Inc,.
https://finance.yahoo.com/news/brk-inc-otc-brkk-isee-163000798.html
I also see there is a Refcam by another company named Vicareo which has been around since 2016. I assume they are competition. Just don't get how they can both use "Refcam?"
https://www.globenewswire.com/news-release/2018/12/12/1665759/0/en/IMT-Vislink-Video-Technology-Powers-Vicareo-RefCam-at-Nationally-Televised-NCAA-College-Football-Games.html
News: NASDAQ delisting on April 30 if not in compliance by then. Final Notice from SEC.
Can anyone tell what is driving this in the past two weeks. Too many posts on Stocktwits to see what is going.
Are they now into Crypto? What is the catalyst? Thanks
If it doesn’t hold .0024 then next Support isn’t until .0019.
It bounced right off the 50 SMA on the 60 minute one month chart. It that doesn’t hold, it is going to .0018 Support.
Very intersting company. Impressed that their products are reviewed on CNET. Haven’t traded this yet. Was wondering about the liquidity. How easy it it to sell shares? Some of these sub pennies won’t fill large blocks or will take a partial fill of your order then lower the price. Some won’t fill AON orders. Just curious what others have experienced. Thanks.
I am trying to open Recent News under the Hot category. It will not load any news. What’s up?
126,000 shares AH. Up $1.05!!
Where are you getting this? Provide a link.
Here is the 8K:
5:28 PM ET 6/14/17 | Dow Jones
HTG Molecular Diagnostics Inc. (HTGM) filed a Form 8K - Other Events - with the U.S Securities and Exchange Commission on June 14, 2017.
Effective June 14, 2017, HTG Molecular Diagnostics, Inc. (the "Company") entered into a statement of work (the "SOW") with QIAGEN Manchester Limited ("QIAGEN"), a U.K. corporation and wholly owned subsidiary of QIAGEN N.V. The SOW was entered into pursuant to the Company's Master Assay Development, Commercialization and Manufacturing Agreement (the "Master Agreement") with QIAGEN, and addresses development activities expected to be conducted by the Company and QIAGEN in connection with the initial phase of a sponsor project agreement entered into between QIAGEN and a pharmaceutical company ("Initial Phase").
Under the SOW, the Company and QIAGEN are expected to perform development work for the Initial Phase of what is expected to become a multi-stage project leading to the potential development and commercialization of a next generation sequencing-based companion diagnostic assay. The development work is expected to support one of the pharmaceutical company's therapeutic development and commercialization programs. QIAGEN will pay the Company low single digit millions of dollars for the Initial Phase development work performed under the SOW, and the Company and QIAGEN will also share in any net profits (as determined under the Master Agreement) generated by the Initial Phase.
In connection with the execution of the SOW, HTG and QIAGEN also amended the Master Agreement, to provide that, in the event of a change in control, neither party will be able to terminate the SOW, or the Master Agreement to the extent it relates to the SOW.
QIAGEN North American Holdings, Inc., a wholly-owned subsidiary of QIAGEN N.V., owns 833,333 shares of our common stock.
These triple leveraged ETFs are pretty scary but exciting. Watching for now.
Good info. Will do. Thanks
Got it. New to leveraged ETFs. You're right - Gotta know before you Go.
Thanks
Question - Why is $UGAZ down big premarket while $DGAZ is up? Don't they both track the same thing?
Question - Why is $UGAZ down big premarket while $DGAZ is up? Don't they both track the same thing?
Beaten down enough. Lots of call buying. Looks like it will hit $25 today.
Thanks. GLTA
Can someone post the link regarding the upcoming June 1st announcement. Thanks
Anyone know what time this analyst meeting is being held?
Cleared it. 100 day next at 6.11
I guess this is not going to retreat below $6 again.
Sold for a nice profit. Will buy back in under $6
Nice early morning pop!
200 MDA is 9.77 Watch this for support.
Crazy for an S&P 500 stock to drop 21% in one day. And that is just over missing earnings!
Testing the low of the day.
Yea. Looks like it might have bottomed.
Looks like it just touched the oversold line.
What's causing the big drop today?
Bought into this at 1.60. See how it turns out.
Doesn't appear to be doing much for the stock. Volume low and price down 4%
Trading in a very narrow range for the past two hours. Volume has slowed. Should close above the day's low. Will watch closely on Monday.
Believe or not, Zacks gave this a buy recommendation yesterday with a target of .75.